Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of the effects of Flt3-ligand in AML cell populations with and without genetic Flt3 abnormalitiesBRUSERUD, Øystein; HOVLAND, Randi; WERGELAND, Line et al.Haematologica (Roma). 2003, Vol 88, Num 4, pp 416-428, issn 0390-6078, 13 p.Article

Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administrationDE KRUIJF, Evert-Jan F. M; HAGOORT, Henny; VELDERS, Gerjo A et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1061-1067, issn 0390-6078, 7 p.Article

Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesisNAKAMORI, Yoshiki; BING LIU; KATAYAMA, Naoyuki et al.British journal of haematology. 2012, Vol 157, Num 6, pp 674-686, issn 0007-1048, 13 p.Article

FLT3 inhibitors: a paradigm for the development of targeted therapeutics for paediatric cancer. CommentaryBROWN, P; SMALL, D; TALLEN, G et al.European journal of cancer (1990). 2004, Vol 40, Num 5, pp 707-724, issn 0959-8049, 18 p.Article

Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatmentLEE KIM SWEE; BOSCO, Nabil; MALISSEN, Bernard et al.Blood. 2009, Vol 113, Num 25, pp 6277-6287, issn 0006-4971, 11 p.Article

FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA VaccinesKREITER, Sebastian; DIKEN, Mustafa; SELMI, Abderraouf et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 19, pp 6132-6142, issn 0008-5472, 11 p.Article

Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in miceROBINSON, S. N; CHAVEZ, J. M; PISAREV, V. M et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 5, pp 361-369, issn 0268-3369, 9 p.Article

Initial evaluation and follow-up of acute radiation syndrome in two patients from the Dakar accidentMARC BERTHO, Jean; ROY, Laurence; SOUIDI, Maamar et al.Biomarkers (London. Print). 2009, Vol 14, Num 2, pp 94-102, issn 1354-750X, 9 p.Article

Cancer gene therapy using in vivo electroporation of Flt3-ligandSHIMAO, Kazuya; TAKAYAMA, Takuya; ENOMOTO, Katsuhisa et al.International journal of oncology. 2005, Vol 27, Num 2, pp 457-463, issn 1019-6439, 7 p.Article

Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccinationBAATARJAV, Tselmeg; KATAOKA, Kosuke; GILBERT, Rebekah S et al.Vaccine. 2011, Vol 29, Num 34, pp 5747-5757, issn 0264-410X, 11 p.Article

A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynxKODAMA, Satoru; HIRANO, Takashi; NODA, Kenji et al.Vaccine. 2010, Vol 28, Num 13, pp 2510-2516, issn 0264-410X, 7 p.Article

Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted TumorsCURRAN, Michael A; ALLISON, James P.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7747-7755, issn 0008-5472, 9 p.Article

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agentsFURUICHI, Yoshiyuki; GOI, Kumiko; XIAOCHUN ZHANG et al.Cancer research (Baltimore). 2007, Vol 67, Num 20, pp 9852-9861, issn 0008-5472, 10 p.Article

Effect of Fit3 ligand gene transfer in experimental pancreatic cancerRYSCHICH, E; HUSZTY, G; WENTZENSEN, N et al.International journal of colorectal disease (Print). 2007, Vol 22, Num 2, pp 215-223, issn 0179-1958, 9 p.Article

Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges : Myeloid biologySTERNBERG, David W; LICHT, Jonathan D.Current opinion in hematology. 2005, Vol 12, Num 1, pp 7-13, issn 1065-6251, 7 p.Article

Prediction of resistance to small molecule FLT3 inhibitors: Implications for molecularly targeted therapy of acute leukemiaCOOLS, Jan; MENTENS, Nicole; FURET, Pascal et al.Cancer research (Baltimore). 2004, Vol 64, Num 18, pp 6385-6389, issn 0008-5472, 5 p.Article

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemiaABU-DUHIER, F. M; GOODEVE, A. C; WILSON, G. A et al.British journal of haematology. 2001, Vol 113, Num 4, pp 983-988, issn 0007-1048Article

Expression of Flt3-ligand by the endothelial cellSOLANILLA, A; GROSSET, C; LEMERCIER, C et al.Leukemia. 2000, Vol 14, Num 1, pp 153-162, issn 0887-6924Article

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationKHARAZI, Shabnam; MEAD, Adam J; RECKZEH, Kristian et al.Blood. 2011, Vol 118, Num 13, pp 3613-3621, issn 0006-4971, 9 p.Article

Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3GEORGE, Prince; BALI, Purva; MOSCINSKI, Lynn et al.Cancer research (Baltimore). 2004, Vol 64, Num 10, pp 3645-3652, issn 0008-5472, 8 p.Article

FLT3 mutations and leukaemiaPANACIOTIS; KOTTARIDIS, D; GALE, Rosemary E et al.British journal of haematology. 2003, Vol 122, Num 4, pp 523-538, issn 0007-1048, 16 p.Article

Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliJEFFORD, Michael; SCHNURR, Max; PARENTE, Phil et al.Blood. 2003, Vol 102, Num 5, pp 1753-1763, issn 0006-4971, 11 p.Article

Antigen-specific IgG elicited in subjects with prostate cancer treated with Flt3 ligandDUNPHY, Edward J; MCNEEL, Douglas G.Journal of immunotherapy (1997). 2005, Vol 28, Num 3, pp 268-275, issn 1524-9557, 8 p.Article

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphomaGREYSTOKE, A; O'CONNOR, Jpb; RADFORD, J et al.British journal of cancer. 2011, Vol 104, Num 4, pp 719-725, issn 0007-0920, 7 p.Article

Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: Possible application for cancer immunotherapyHARADA, Sachio; KIMURA, Takafumi; FUJIKI, Hiroshi et al.International journal of oncology. 2007, Vol 30, Num 6, pp 1461-1468, issn 1019-6439, 8 p.Article